gotop

最新消息

  • link
    華上生醫獲得經濟部核准為生技新藥公司增列品項
    華上生醫研發製造產品之「GNTbm-CT-01」、「GNTbm-38」等二項,獲得經濟部核准為生技新藥公司增列品項。
    2021-08-18
  • link
    GNTbm’s Trial on New Epigenetic Drug Generates Hope for Patients with Breast Cancer
    GNTbm’s Trial on New Epigenetic Drug Generates Hope for Patients with Breast Cancer.
    2021-07-23
  • link
    華上生醫7/8登興櫃 每股參考價30元
    華上生醫7/8登興櫃 每股參考價30元
    2021-07-05
  • link
    2021/6/30本公司獲准登錄興櫃,7月8日開始興櫃買賣
    2021/6/30本公司獲准登錄興櫃,7月8日開始興櫃買賣
    2021-07-01
  • link
    華上生醫自主開發「A PHARMACEUTICAL COMBINATION AND METHOD FOR REGULATION OF TUMOR MICROENVIRONMENT AND IMMUNOTHERAPY」取得南非發明專利
    華上生醫自主開發「A PHARMACEUTICAL COMBINATION AND METHOD FOR REGULATION OF TUMOR MICROENVIRONMENT AND IMMUNOTHERAPY」取得南非發明專利
    2021-03-02
  • link
    華上生醫自主開發「A PHARMACEUTICAL COMBINATION AND METHOD FOR REGULATION OF TUMOR MICROENVIRONMENT AND IMMUNOTHERAPY」取得俄羅斯發明專利
    華上生醫自主開發「A PHARMACEUTICAL COMBINATION AND METHOD FOR REGULATION OF TUMOR MICROENVIRONMENT AND IMMUNOTHERAPY」取得俄羅斯發明專利
    2021-01-27